Immune Globulin Treatment for Stiff Person Syndrome
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial tests whether an intravenous immune globulin (a purified blood protein that regulates immunity) can reduce muscle stiffness and spasms in adults with stiff person syndrome. If it works, this treatment could offer a new option for people whose muscles become abnormally rigid and painful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have been diagnosed with stiff person syndrome with specific muscle stiffness or spasms, confirmed by blood or spinal fluid tests
- Your muscle stiffness primarily affects your trunk, lower back, and legs
- You have not received immune globulin treatment in the past 3 months
- Your daily symptom medications have been stable for at least 2 weeks before screening
- You are able to travel to the study site regularly and keep a symptom diary
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called efgartigimod to see if it can reduce muscle stiffness and spasms in people with Stiff Person Syndrome. If you have GAD antibodies and stable symptoms, you might be able to join.
This 24-month study helps doctors improve how they treat muscle stiffness (spasticity) that develops after stroke. You'll work with a research team to track your recovery and test better ways to reduce stiffness and improve movement.
This trial tests a spinal cord stimulator to reduce muscle stiffness (spasticity) after a stroke. If you've had arm or leg tightness that hasn't improved with other treatments, this device might help you move more easily.
This trial tests if a treatment called ITB (intrathecal baclofen) can help reduce muscle stiffness in people with hereditary spastic paraplegia (HSP). Participants will receive the treatment and be followed over time to see how well it works.
This study tests an investigational drug (BMS-986368) to see if it helps reduce muscle stiffness and spasms caused by multiple sclerosis. It may be an option if you have had spasticity for at least 6 months and are not currently using other treatments that cannot be paused.
This study tests an investigational botulinum toxin injection (YY001) to reduce muscle stiffness in the arm after a stroke. It may help you move your arm more easily and improve daily tasks.
Hear when a new Stiff Person Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.